Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
  CD74-NRG1 fusions in lung adenocarcinoma

Fernandez-Cuesta, L., Plenker, D., Osada, H., Sun, R., Menon, R., Leenders, F., et al. (2014). CD74-NRG1 fusions in lung adenocarcinoma. Cancer Discovery, 4(4), 415-422. doi:10.1158/2159-8290.CD-13-0633.

Item is

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Fernandez-Cuesta, Lynette1, Autor           
Plenker, Dennis2, Autor
Osada, Hirotaka2, Autor
Sun, Ruping2, Autor
Menon, Roopika2, Autor
Leenders, Frauke2, Autor
Ortiz-Cuaran, Sandra2, Autor
Peifer, Martin3, Autor           
Bos, Marc2, Autor
Daßler, Juliane2, Autor
Malchers, Florian3, Autor           
Schöttle, Jakob1, Autor           
Vogel, Wenzel2, Autor
Dahmen, Ilona2, Autor
Koker, Mirjam3, Autor           
Ullrich, Roland T.1, Autor           
Wright, Gavin M.2, Autor
Russell, Prudence A.2, Autor
Wainer, Zoe2, Autor
Solomon, Ben2, Autor
Brambilla, Elisabeth2, AutorNagy-Mignotte, Helene2, AutorMoro-Sibilot, Denis2, AutorBrambilla, Christian G.2, AutorLantuejoul, Sylvie2, AutorAltmüller, Janine2, AutorBecker, Christian2, AutorNürnberg, Peter2, AutorHeuckmann, Johannes M.3, Autor           Stoelben, Erich2, AutorPetersen, Iver2, AutorClement, Joachim H.2, AutorSänger, Jörg2, AutorMuscarella, Lucia A.2, Autorla Torre, Annamaria2, AutorFazio, Vito M.2, AutorLahortiga, Idoya2, AutorPerera, Timothy2, AutorOgata, Souichi2, AutorParade, Marc2, AutorBrehmer, Dirk2, AutorVingrom, Martin2, AutorHeukamp, Lukas C.2, AutorBuettner, Reinhard2, AutorZander, Thomas1, Autor           Wolf, Johanna2, AutorPerner, Sven2, AutorAnsen, Sascha2, AutorHaas, Stefan A.2, AutorYatabe, Yasushi2, AutorThomas, Roman K.3, Autor            mehr..
Affiliations:
1Klinisches PET, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149663              
2a Department of Translational Genomics, University Hospital Cologne, Center of Integrated Oncology Cologne-Bonn, Germany b Department I of Internal Medicine, University Hospital Cologne, Center of Integrated Oncology Cologne-Bonn, Germany c Laboratory of Translational Cancer Genomics, University Hospital Cologne, Center of Integrated Oncology Cologne-Bonn, Germany d Network Genomic Medicine, University Hospital Cologne, Center of Integrated Oncology Cologne-Bonn, Germany e Center for Molecular Medicine Cologne (CMMC), University of Cologne, Germany f Cologne Center for Genomics (CCG), University of Cologne, Germany g Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Germany h Department of Pathology, University Hospital Medical Center, University of Cologne, Germany i Blackfield AG, Germany j Thoracic Surgery, Lungenklinik Merheim, Kliniken der Stadt Köln gGmbH, Cologne, Germany k Institute of Human Genetics, Cologne, Germany l Computational Molecular Biology Department, Max Planck Institute for Molecular Genetics, Berlin, Germany m Department of Prostate Cancer Research, Institute of Pathology, University Hospital Bonn, Bonn, Germany n Institute for Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany o Institute of Pathology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany p Department of Internal Medicine II, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany q Institute for Pathology Bad Berka, Bad Berka, Germany r Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan s Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan t Departments of Surgery, St. Vincent's Hospital, Australia u Departments of Pathology, St. Vincent's Hospital, Australia v Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia w Department of Pathology, Grenoble-Alpes University, Grenoble, France x CHU Grenoble Institut National de la Santé et de la Recherche Medicale (INSERM) U823, Institute Albert Bonniot, Grenoble-Alpes University, Grenoble, France y Laboratory of Oncology IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy aa Laboratory for Molecular Medicine and Biotechnology, University Campus Bio-Medico, Rome, Italy ab Center for the Biology of Disease, VIB, Leuven, Belgium ac Oncology Discovery, Janssen Research and Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium, ou_persistent22              
3Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149656              

Inhalt

einblenden:
ausblenden:
Schlagwörter: -
 Zusammenfassung: © 2014 American Association for Cancer Research.

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 2014
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: Expertenbegutachtung
 Identifikatoren: eDoc: 695280
DOI: 10.1158/2159-8290.CD-13-0633
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: Cancer Discovery
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: -
Seiten: - Band / Heft: 4 (4) Artikelnummer: - Start- / Endseite: 415 - 422 Identifikator: ISSN: 21598290S